ScoreWhy is Axsome Therapeutics, Inc. ?
1
With a growth in Net Sales of 14.62%, the company declared Very Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at USD -100.95 MM
- NET SALES(Q) Highest at USD 170.99 MM
- RAW MATERIAL COST(Y) Fallen by -1.84% (YoY)
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 22.90%, its profits have risen by 19.6%
3
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -0.66% over the previous quarter and currently hold 1.19% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
4
Market Beating performance in long term as well as near term
- Along with generating 22.90% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Axsome Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Axsome Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Axsome Therapeutics, Inc.
25.25%
3.00
40.40%
S&P 500
13.68%
0.71
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
254.80%
EBIT Growth (5y)
-150.60%
EBIT to Interest (avg)
-26.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.20
Sales to Capital Employed (avg)
1.20
Tax Ratio
0.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
86.64%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
109.78
EV to EBIT
-40.85
EV to EBITDA
-42.77
EV to Capital Employed
-131.19
EV to Sales
14.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-273.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -100.95 MM
NET SALES(Q)
Highest at USD 170.99 MM
RAW MATERIAL COST(Y)
Fallen by -1.84% (YoY
OPERATING PROFIT(Q)
Highest at USD -30.51 MM
OPERATING PROFIT MARGIN(Q)
Highest at -17.84 %
PRE-TAX PROFIT(Q)
Highest at USD -34.04 MM
NET PROFIT(Q)
Highest at USD -34.04 MM
EPS(Q)
Highest at USD -0.94
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Axsome Therapeutics, Inc.
Operating Cash Flow
Highest at USD -100.95 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 170.99 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
At USD 170.99 MM has Grown at 38.17%
over average net sales of the previous four periods of USD 123.76 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD -30.51 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -17.84 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -34.04 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -34.04 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.94
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -1.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 2.41 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
